Use access key #2 to skip to page content.
$8.24 0.24 (3.00%)
11/21/2008 4:00 PM

Clinical Data, Inc. (CLDA)

CAPS Rating:
*

The Company operates business in three reporting segments: Molecular Services, Clinics and Small Hospitals and All Other.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating CLDA

Add Stock to Watchlist

What the Community Thinks

Total Members

28 Outperforms
11 Underperforms
 

All-Stars

2 Outperforms
8 Underperforms
 

Wall Street

1 Outperforms
0 Underperforms
 

Members bullish on CLDA are also bullish on:

Members bearish on CLDA are also bearish on:

Ticker Tags

Micro Cap (5043), Technical Instruments (65), Life Sciences Tools and Services (59)
Suggest a tag

Clinical Data, Inc. At A Glance

Current Price: $8.24
Last Trade Time: 11/21/2008 4:00 PM
Open: $8.11
Previous Close: $8.00
Daily Range: $7.15 - $8.54
52-Week Range: $7.82 - $25.81
Volume: 68,391
Market Cap: $181.94M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

CLDA VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for CLDA

More Headlines...

Top Bull Pitch

Recs

0

Clinical Data, Inc. (CLDA)

Avatar riley20 (< 20) Submitted: 9/06/06 2:07 AM

heavy insider buying....personalized medicine will be big soon

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 8 :   1 2 Next »

Recs

0

 (CLDA)

Avatar JayHawk405 (79.12) Submitted: 11/11/07 5:29 PM : Outperform Start Price: $24.47 CLDA Score: -18.55

Drug reseach for baby boomers is on the rise.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CLDA)

Avatar spitfire1980fan (47.66) Submitted: 10/04/07 7:54 AM : Outperform Start Price: $25.40 CLDA Score: -16.77

Great management and growing in the right direction in the area of personalized medicine. The FDA is looking for companies like this to make medicine safer for everyone (recent warfarin lable change), they will do everything they can to work with CLDA through the processes of new drugs/tests as they both want the same thing......safer drugs with less side effects. A true pure play in personalized medicine here.............It's the future folks.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CLDA)

Avatar arn7 (91.31) Submitted: 9/23/07 4:45 PM : Outperform Start Price: $22.82 CLDA Score: -13.64

personalized medicine will be big

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CLDA)

Avatar chelstad (< 20) Submitted: 9/11/07 2:36 PM : Outperform Start Price: $18.87 CLDA Score: -7.79

CEO bought in

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CLDA)

Avatar doug2beth (< 20) Submitted: 9/10/07 3:58 PM : Outperform Start Price: $19.45 CLDA Score: -9.70

I started to follow this company when it was called LDNA, profitable & nitch market. They got bought out a couple of times- not good. GNSC screwed them big time. When some one figures out what they really have here, then you will thank me. This is a stock of the future with huge potential.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 8 :   1 2 Next »

Wall Street

Results 1 - 1 of 1  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRothCapital < 20 09/30/08 Outperform NS $15.67-47.42%-33.33%-14.09

Results 1 - 1 of 1  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links